Reclast vs Prolia: Babban Bambanci da kamanceceniya

Magunguna vs. Aboki

Reclast (zoledronic acid) da Prolia (denosumab) wasu magunguna ne guda biyu na allura waɗanda ake amfani da su don magance cutar sanyin ƙashi a cikin mata masu haihuwa. Hakanan za'a iya amfani dasu don magance osteoporosis a cikin wasu maza. Kodayake Reclast da Prolia suna aiki ne ta hana toshewar kashi da kuma kara kashi, amma suna da wasu bambance-bambance daban daban da za a lura dasu.

Maimaitawa

Reclast (Menene Reclast?) Shine sunan alama don acid zoledronic. Magungunan bisphosphonate ne wanda ake amfani dashi don magancewa da hana cutar sanyin ƙashi a cikin mata bayan haihuwa. Hakanan za'a iya amfani dashi don ƙara yawan kasusuwa a cikin wasu maza tare da osteoporosis. Bugu da ƙari, waɗanda suka ci gaba da matsalar yawan kashi daga amfani da glucocorticoid ko cutar Paget za a iya magance su tare da Reclast.

Ana gudanar da reclastas azaman allura ko jiko. Ana samun shi azaman magani na 5 mg / 100 mL wanda za'a iya bashi sau ɗaya a kowace shekara ko kowace shekara 2 ya danganta da yanayin da ake bi. Abubuwan da yafi tasiri na Reclast shine zazzabi da ciwon tsoka bayan gudanarwa.

Prolia

Prolia (Menene Prolia?) Sunan suna ne na denosumab. An rarraba shi azaman wakili na anti-RANKL wanda ke aiki ta hanyar toshe samuwar osteoclasts don ƙara yawan ƙashi. Prolia na iya yin maganin maza da mata masu fama da cutar sanyin kashi tare da sanyin kashi ko kuma haɗarin karaya saboda wasu yanayi.

Ana samun Prolia azaman bayani na 60 mg / 1 mL wanda ake gudanarwa ta hanyar subercaneously kowane watanni 6. Waɗanda suka karɓi Prolia kuma dole ne su sha alli da bitamin D a kowace rana saboda ƙarin haɗarin hypocalcemia, ko ƙarancin alli a cikin jiki.

Reclast vs Prolia Side by Kwatantawa gefe

Reclast da Prolia sune ire-iren kwayoyi tare da manufofin kulawa na gama gari. Koyaya, suna da wasu kamanceceniya da mahimmancin ra'ayi waɗanda za'a iya samun su a ƙasa.

Samu takardar takardar sayan magani

Maimaitawa	Prolia
An Wadda Domin
Postmenopausal osteoporosis (magani da rigakafin) Osteoporosis a cikin maza Cutar Paget ta kashi	Postmenopausal osteoporosis (magani) Osteoporosis a cikin maza Riskara yawan haɗarin karaya a cikin maza da mata
Rarraba Magunguna
Bisphosphonate	Anti-RANKL wakili
Maƙerin kaya
Novartis	Amgen
Illolin Gaggawa
Zazzaɓi Ciwon tsoka Ciwon kai Hadin gwiwa Jin zafi a hannaye da ƙafa Alamun mura kamar na mura Ciwan Amai Gudawa Kumburin ido	Ciwon baya Ciwon tsoka Jin zafi a hannaye da ƙafa Hadin gwiwa Babban cholesterol Ciwon ciki Pancreatitis Nasopharyngitis
Akwai janar?
Ee, acid zoledronic.	Babu jabu a halin yanzu.
Shin inshora ne ke rufe shi?
Ya bambanta bisa ga mai ba ka sabis	Ya bambanta bisa ga mai ba ka sabis
Sigogi Forms
Magani ga allura	Magani ga allura
Matsakaicin Farashin Kuɗi
$ 1,140 na 100ml	$ 1,422 don 60ml
SingleCare rangwamen Farashi
Farashin farashin	Farashin Prolia
Magungunan Magunguna
Aminoglycosides (gentamicin, tobramycin, da sauransu) Madauki madaukai (furosemide, torsemide, da sauransu) Magungunan Nephrotoxic Digoxin	Babu wata mahimman hulɗar miyagun ƙwayoyi da aka ruwaito
Zan iya amfani da shi yayin tsara ciki, ciki, ko shayarwa?
Reclast yana cikin Ciki Nauyin D. Bai kamata a sha shi yayin daukar ciki ba. Tuntuɓi likita game da matakan da za a ɗauka yayin tsara ciki ko shayarwa.	Prolia tana cikin Jinsi na Yanayi na X kuma yana iya haifar da lahani ga ɗan tayi lokacin da aka yi wa mata masu ciki. Ba a ba da shawarar Prolia a cikin mata masu juna biyu ba

Takaitawa

Reclast (zoledronic acid) da Prolia (denosumab) wasu ƙwayoyi ne guda biyu na allura waɗanda ke magance cutar sanyin ƙashi. Duk da yake dukkanin magungunan biyu na iya magance cututtukan sankara bayan haihuwa, an kuma yarda da Reclast don hana kamuwa da cutar sanyin bayan haihuwa. Dukansu Reclast da Prolia suna iya rage haɗarin karaya ga wasu maza da mata tare da wasu halaye.

Ana gudanar da reclast sau ɗaya a shekara ko sau ɗaya a kowace shekara 2 yayin da ake gudanar da Prolia kowane watanni 6. Hakanan ana buƙatar shan Prolia tare da ƙarin alli da bitamin D don hana hypocalcemia. Koyaya, da Reclast da Prolia duk ba'a basu shawarar ba a cikin yanayin hypocalcemia da aka riga aka kafa.

A cikin binciken kwatancen guda ɗaya na zoledronic acid da denosumab, denosumab ya nuna ƙaruwa mai yawa a cikin ƙananan ƙashi na kashin baya (BMD) idan aka kwatanta da acid zoledronic. Hakanan Zoledronic acid ya nuna mafi yawan alamun kamuwa da mura. Dangane da wannan binciken, Prolia na iya zama mafi tasiri ga wasu mutane.

Yana da mahimmanci a tuntuɓi shawarar likita lokacin tantance mafi kyawun zaɓi na magani. Duk da yake duka magungunan suna da tasiri, ɗayan na iya zama mafi dacewa dangane da wasu dalilai kamar tarihin likita da sauran magungunan da ake sha.